Blackstone Can Deal With Rising Rates Blackstone in the third quarter generated over $800 million more of distributable earnings through net realizations than it did a year earlier. Photo: Nina Westervelt for The Wall Street Journal
Author: Wall Street Journal
Post
DWAC, the Trump Social-Media SPAC, Quadruples on First Day
DWAC, the Trump Social-Media SPAC, Quadruples on First Day Donald Trump’s access to social-media platforms such as Twitter and Facebook was sharply restricted following the Jan. 6 riot at the U.S. Capitol. Photo: JEENAH MOON/REUTERS
Post
Fed Imposes New Restrictions on Officials' Investment Activities
Fed Imposes New Restrictions on Officials' Investment Activities The Federal Reserve building in Washington. Photo: JOSHUA ROBERTS/REUTERS
Post
Wireless Carriers Are Winning 5G Customers for the Wrong Reason
Wireless Carriers Are Winning 5G Customers for the Wrong Reason Wireless carriers have been selling 5G hard over the past couple of years, such as this Verizon 5G advertisement in New York. Photo: John Nacion/Zuma Press
Post
America's Housing Boom Will Keep Builders and Agents Busy
America's Housing Boom Will Keep Builders and Agents Busy The housing-supply problem has been years in the making. A home for sale in San Rafael, Calif. Photo: Justin Sullivan/Getty Images
Post
Bitcoin Is Back Near Record Highs. Houston Pension Fund Dives In.
Bitcoin Is Back Near Record Highs. Houston Pension Fund Dives In. Bitcoin climbed to a record of more than $66,000 earlier this week. Photo: brendan mcdermid/Reuters
Post
PayPal Shares Fall After News of Pinterest Talks
PayPal Shares Fall After News of Pinterest Talks A potential Pinterest acquisition would bring PayPal hundreds of millions of new users but carries risk. Photo: fabrizio bensch/Reuters
Post
U.S. Home Sales Jumped 7% in September
U.S. Home Sales Jumped 7% in September Demand from home buyers has outstripped supply for more than a year. Photo: Justin Sullivan/Getty Images
Post
Pfizer-BioNTech Booster 95.6% Effective in Trial, Companies Say
Pfizer-BioNTech Booster 95.6% Effective in Trial, Companies Say A third dose of the Pfizer-BioNTech Covid-19 vaccine has been authorized for adults 65 years and older and others at high risk. Photo: Bob Daemmrich/Zuma Press
Post
What Happened When United Stopped Trying to Predict the Pandemic
What Happened When United Stopped Trying to Predict the Pandemic